China
· Delayed Price · Currency is CNY Zhangzhou Pientzehuang Pharmaceutical., Statistics
Total Valuation
Zhangzhou Pientzehuang Pharmaceutical., has a market cap or net worth of CNY 148.10 billion. The enterprise value is 146.59 billion.
| Market Cap | 148.10B |
| Enterprise Value | 146.59B |
Important Dates
The next estimated earnings date is Tuesday, April 15, 2025.
| Earnings Date | Apr 15, 2025 |
| Ex-Dividend Date | Oct 22, 2024 |
Share Statistics
Zhangzhou Pientzehuang Pharmaceutical., has 603.32 million shares outstanding. The number of shares has increased by 0.24% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 603.32M |
| Shares Change (YoY) | +0.24% |
| Shares Change (QoQ) | -0.56% |
| Owned by Insiders (%) | 4.49% |
| Owned by Institutions (%) | 8.16% |
| Float | 230.45M |
Valuation Ratios
The trailing PE ratio is 48.12 and the forward PE ratio is 42.88. Zhangzhou Pientzehuang Pharmaceutical.,'s PEG ratio is 2.31.
| PE Ratio | 48.12 |
| Forward PE | 42.88 |
| PS Ratio | 13.58 |
| PB Ratio | 10.56 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 147.00 |
| P/OCF Ratio | n/a |
| PEG Ratio | 2.31 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 40.34, with an EV/FCF ratio of 145.50.
| EV / Earnings | 47.60 |
| EV / Sales | 13.44 |
| EV / EBITDA | 40.34 |
| EV / EBIT | 41.69 |
| EV / FCF | 145.50 |
Financial Position
The company has a current ratio of 5.12, with a Debt / Equity ratio of 0.08.
| Current Ratio | 5.12 |
| Quick Ratio | 1.36 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.32 |
| Debt / FCF | 1.17 |
| Interest Coverage | 93.45 |
Financial Efficiency
Return on equity (ROE) is 22.05% and return on invested capital (ROIC) is 14.50%.
| Return on Equity (ROE) | 22.05% |
| Return on Assets (ROA) | 12.89% |
| Return on Capital (ROIC) | 14.50% |
| Revenue Per Employee | 3.91M |
| Profits Per Employee | 1.10M |
| Employee Count | 2,789 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 1.65 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.56% in the last 52 weeks. The beta is 0.78, so Zhangzhou Pientzehuang Pharmaceutical.,'s price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -3.56% |
| 50-Day Moving Average | 230.93 |
| 200-Day Moving Average | 223.02 |
| Relative Strength Index (RSI) | 54.40 |
| Average Volume (20 Days) | 2,463,215 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Zhangzhou Pientzehuang Pharmaceutical., had revenue of CNY 10.91 billion and earned 3.08 billion in profits. Earnings per share was 5.10.
| Revenue | 10.91B |
| Gross Profit | 4.85B |
| Operating Income | 3.52B |
| Pretax Income | 3.66B |
| Net Income | 3.08B |
| EBITDA | 3.60B |
| EBIT | 3.52B |
| Earnings Per Share (EPS) | 5.10 |
Balance Sheet
The company has 3.27 billion in cash and 1.17 billion in debt, giving a net cash position of 2.10 billion or 3.47 per share.
| Cash & Cash Equivalents | 3.27B |
| Total Debt | 1.17B |
| Net Cash | 2.10B |
| Net Cash Per Share | 3.47 |
| Equity (Book Value) | 14.60B |
| Book Value Per Share | 23.24 |
| Working Capital | 12.75B |
Cash Flow
In the last 12 months, operating cash flow was 1.13 billion and capital expenditures -118.52 million, giving a free cash flow of 1.01 billion.
| Operating Cash Flow | 1.13B |
| Capital Expenditures | -118.52M |
| Free Cash Flow | 1.01B |
| FCF Per Share | 1.67 |
Margins
Gross margin is 44.49%, with operating and profit margins of 32.23% and 28.23%.
| Gross Margin | 44.49% |
| Operating Margin | 32.23% |
| Pretax Margin | 33.55% |
| Profit Margin | 28.23% |
| EBITDA Margin | 32.99% |
| EBIT Margin | 32.23% |
| FCF Margin | 9.24% |
Dividends & Yields
This stock pays an annual dividend of 2.32, which amounts to a dividend yield of 0.94%.
| Dividend Per Share | 2.32 |
| Dividend Yield | 0.94% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 6 |
| Payout Ratio | 46.53% |
| Buyback Yield | -0.24% |
| Shareholder Yield | 0.70% |
| Earnings Yield | 2.08% |
| FCF Yield | 0.68% |
Stock Splits
The last stock split was on May 24, 2016. It was a forward split with a ratio of 1.5.
| Last Split Date | May 24, 2016 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
Zhangzhou Pientzehuang Pharmaceutical., has an Altman Z-Score of 27.3.
| Altman Z-Score | 27.3 |
| Piotroski F-Score | n/a |